ストックスクリーナーアプリを入手
67.10
0.53%
-0.36
アフターアワーズ：
67.28
0.18
+0.27%
前日終値:
$67.46
開ける：
$68.23
24時間の取引高:
10.65M
Relative Volume:
1.05
時価総額：
$81.97B
収益：
$378.96B
当期純損益:
$5.28B
株価収益率:
16.01
EPS:
4.19
ネットキャッシュフロー:
$5.94B
1週間 パフォーマンス:
+3.34%
1か月 パフォーマンス:
+5.40%
6か月 パフォーマンス:
+21.25%
1年 パフォーマンス:
+20.04%
1日の値動き範囲:
$66.91
$68.28
1週間の範囲:
$64.42
$72.51
52週間の値動き範囲:
$43.56
$72.51
Cvs Health Corp Stock (CVS) Company Profile
CVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
67.10 | 81.97B | 378.96B | 5.28B | 5.94B | 4.19 |
|
UNH
Unitedhealth Group Inc
|
404.81 | 382.29B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
416.30 | 93.50B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
333.01 | 90.77B | 244.38B | 3.43B | 8.96B | 12.24 |
|
HUM
Humana Inc
|
256.69 | 31.77B | 117.76B | 1.21B | 2.39B | 9.95 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-13 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | アップグレード | Edward Jones | Hold → Buy |
| 2024-12-03 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-11-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-10-04 | アップグレード | TD Cowen | Hold → Buy |
| 2024-05-30 | 開始されました | Robert W. Baird | Neutral |
| 2024-05-07 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-05-02 | ダウングレード | UBS | Buy → Neutral |
| 2024-05-01 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2023-12-22 | 開始されました | HSBC Securities | Buy |
| 2023-09-19 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-09-12 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | ダウングレード | Edward Jones | Buy → Hold |
| 2023-05-26 | 開始されました | Piper Sandler | Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 再開されました | Morgan Stanley | Overweight |
| 2022-06-17 | 開始されました | Loop Capital | Buy |
| 2022-05-27 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-02-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 開始されました | Goldman | Buy |
| 2021-12-01 | 開始されました | Seaport Research Partners | Buy |
| 2021-05-19 | 開始されました | Wells Fargo | Equal Weight |
| 2021-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-01-08 | アップグレード | Jefferies | Hold → Buy |
| 2020-09-17 | 開始されました | Piper Sandler | Overweight |
| 2020-07-01 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-05-14 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 再開されました | RBC Capital Mkts | Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Buy |
| 2019-06-05 | アップグレード | Standpoint Research | Hold → Buy |
| 2019-04-29 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 開始されました | Guggenheim | Buy |
| 2019-04-15 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-13 | 開始されました | Bernstein | Outperform |
| 2019-02-20 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-18 | 開始されました | Barclays | Overweight |
| 2018-11-29 | 再開されました | Goldman | Neutral |
| 2018-11-28 | 開始されました | Evercore ISI | Outperform |
| 2018-10-26 | 再開されました | Wolfe Research | Peer Perform |
| 2018-07-09 | アップグレード | Citigroup | Neutral → Buy |
| 2018-02-27 | 再開されました | BofA/Merrill | Buy |
| 2018-02-13 | 繰り返されました | Citigroup | Neutral |
すべてを表示
Cvs Health Corp (CVS) 最新ニュース
RBC Capital Raises Price Target for CVS Health to $81 | CVS Stock News - GuruFocus
RBC Capital Boosts Price Target for CVS to $81 Following Q1 Results | CVS Stock News - GuruFocus
CVS Health (CVS) Price Target Boosted by Analyst Following Positive Outlook | CVS Stock News - GuruFocus
Comerica Bank Reduces Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS (CVS) Embarks on Strategic Shift Amidst Health Sector Challenges - GuruFocus
2 Healthcare Stocks to Research Further and 1 to Be Wary Of - The Globe and Mail
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - Investing.com India
One68 Global Capital LLC Acquires Shares of 80,597 CVS Health Co. (NYSE:CVS) - MarketBeat
8 Knots Management LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Is CVS Health Corporation (CVS) The Best Stock To Buy and Hold For 10 Years? - Insider Monkey
CVS Health (CVS) Exceeds Earnings Expectations, Analysts Maintain Revenue Forecasts - GuruFocus
CVS Health rides improving Medicare business to better-than-expected first quarter - LancasterOnline
CVS Health (CVS) Exceeds Q1 Expectations with Revenue and EPS Gains - GuruFocus
12 Best Stocks to Buy and Hold For 10 Years - Insider Monkey
CVS Health Corporation (NYSE:CVS) Q1 2025 Earnings Call Transcript - Insider Monkey
Whitebox Advisors LLC Acquires New Shares in CVS Health Co. (NYSE:CVS) - MarketBeat
Freestone Grove Partners LP Buys Shares of 806,575 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Rides Improving Medicare Business In First Quarter - Post Journal
UBS Raises Price Target for CVS Health (CVS) to $71 | CVS Stock News - GuruFocus
CVS Health Stock Price | CVS Stock Quote, News, and History - markets.businessinsider.com
A Glimpse Into The Expert Outlook On CVS Health Through 10 Analysts - Benzinga
CVS (CVS) Shows Resilience with Solid Earnings Amid Healthcare Shifts - GuruFocus
CVS makes deal to make popular weight loss drug cheaper - TheStreet
CVS Health Raises Forecast After Strong Q1 Results - Finimize
Health Insurance Market Size to Lead USD 5,190 Bn by 2034 Rising chronic diseases and healthcare costs are fueling demand for coverage - GlobeNewswire Inc.
CVS Health (CVS) Target Price Raised to $82 by Barclays | CVS Stock News - GuruFocus
CVS reports strong Q1 earnings, will exit Aetna’s ACA plans - InsuranceNewsNet
Eli Lilly Tackles CVS Health's Cut In Zepbound Coverage - Finimize
CVS Decision Sparks Reaction in Market, Impact on Eli Lilly Anal - GuruFocus
CVS Health (CVS) Target Price Upped by BofA Amid Positive Outloo - GuruFocus
CVS Decision Sparks Reaction in Market, Impact on Eli Lilly Analyzed | CVS Stock News - GuruFocus
CVS Health (CVS) Target Price Upped by BofA Amid Positive Outlook | CVS Stock News - GuruFocus
CVS Health (CVS) Gains After Surpassing Earnings Estimates and S - GuruFocus
Northern Trust Corp Has $560.76 Million Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight - GuruFocus
CVS (CVS) Faces DOJ Allegations of Discriminatory Practices - GuruFocus
CVS Health Corp (CVS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
CVS Health Reports Strong Q1 2025 Results - TipRanks
What Are Wall Street Analysts' Target Price for CVS Health Stock? - MSN
Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge - Reuters
CVS Health’s Q1 2025 Earnings Call: Strong Results and Optimistic Outlook - TipRanks
Obesity Drug Price Wars Heating Up as CVS Picks Novo Over Lilly - Bloomberg.com
DOJ sues insurers over alleged Medicare Advantage kickbacks - Modern Healthcare
Zepbound Grows, But CVS/Novo Nordisk Deal For Wegovy Casts Shadow - insights.citeline.com
CVS Caremark to Place Wegovy as Preferred GLP-1 for Weight Loss - Managed Healthcare Executive
US accuses health insurers, brokers of Medicare Advantage kickback scheme - Reuters
CVS Health raises annual profit forecast as turnaround gathers steam - MSN
CVS Drops Lilly’s Zepbound from Preferred Coverage in Novo Win - Bloomberg.com
Oxford Asset Management LLP Raises Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge By Reuters - Investing.com
CVS Faces Legal Action Over Alleged Medicare Advantage Kickbacks | CVS Stock News - GuruFocus
Cvs Health Corp (CVS) 財務データ
収益
当期純利益
現金流量
EPS
0.52%
1.54%
大文字化:
|
ボリューム (24 時間):